{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:02:40Z","timestamp":1790845360011,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100016017","name":"Duke-NUS Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pathol.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:20:56Z","timestamp":1701883256000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8592-5018","authenticated-orcid":false,"given":"Timothy Kwang Yong","family":"Tay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5071-2601","authenticated-orcid":false,"given":"Gek San","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Say Hwee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Xiu","family":"Sam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse Hui","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-5936","authenticated-orcid":false,"given":"Jeremy Wee Kiat","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Shao Weng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Kiat Hon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2023.10.011_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-020-0377-z","article-title":"MET-dependent solid tumors - molecular diagnosis and targeted therapy","volume":"17","author":"Guo","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.pathol.2023.10.011_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.pathol.2023.10.011_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00428-016-2025-7","article-title":"Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL","volume":"470","author":"Deans","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2023.10.011_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18632\/oncotarget.28188","article-title":"Positive predictive value of ERBB2 copy number gain by tissue or circulating tumour DNA next-generation sequencing across advanced cancers","volume":"13","author":"Shah","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2023.10.011_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12935-022-02761-1","article-title":"HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry","volume":"22","author":"Morsberger","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.pathol.2023.10.011_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12032-021-01482-1","article-title":"Estimating copy number using next-generation sequencing to determine ERBB2 amplification status","volume":"38","author":"Nakamura","year":"2021","journal-title":"Med Oncol"},{"key":"10.1016\/j.pathol.2023.10.011_bib7","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1007\/s12253-020-00844-w","article-title":"Evaluation of next generation sequencing for detecting HER2 copy number in breast and gastric cancers","volume":"26","author":"Niu","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.pathol.2023.10.011_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jmoldx.2016.09.010","article-title":"Next-generation assessment of human epidermal growth factor Receptor 2 (ERBB2) amplification status: clinical validation in the context of a hybrid capture-based, comprehensive solid tumour genomic profiling assay","volume":"19","author":"Ross","year":"2017","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.pathol.2023.10.011_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gcc.22431","article-title":"Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance","volume":"56","author":"Pfarr","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.pathol.2023.10.011_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","article-title":"Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data","volume":"17","author":"Grasso","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.pathol.2023.10.011_bib11","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1158\/1078-0432.CCR-22-1321","article-title":"Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors","volume":"28","author":"Solomon","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2023.10.011_bib12","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.3390\/cancers13195023","article-title":"MET amplification in non-small cell lung cancer (NSCLC)-a consecutive evaluation using next-generation sequencing (NGS) in a real-world setting","volume":"13","author":"Schubart","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pathol.2023.10.011_bib13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.18632\/oncotarget.28092","article-title":"Comparison of MET gene amplification analysis by next-generation sequencing and fluorescence in situ hybridization","volume":"12","author":"Schmitt","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2023.10.011_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40164-021-00245-y","article-title":"MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors","volume":"10","author":"Peng","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.pathol.2023.10.011_bib15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.csbj.2019.09.003","article-title":"Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumours","volume":"17","author":"Heydt","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"issue":"Suppl 5","key":"10.1016\/j.pathol.2023.10.011_bib16","doi-asserted-by":"crossref","first-page":"V800","DOI":"10.1093\/annonc\/mdz269.009","article-title":"Identification of MET gene amplifications using next-generation sequencing in non-small cell lung cancer patients","volume":"30","author":"Clav\u00e9","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2023.10.011_bib17","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2023.10.011_bib18","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pathol.2023.10.011_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/humu.22825","article-title":"Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing","volume":"36","author":"Samorodnitsky","year":"2015","journal-title":"Hum Mutat"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523003082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523003082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T21:58:27Z","timestamp":1710453507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523003082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0031302523003082"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2023.10.011","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}